Michael Amatangelo, PhD^1*, Nicholas Stong^1*, Paulo Maciag^1*, Anna Sureda Balari, MD, PhD², Niels W.C.J. van de Donk, MD, PhD^3*, Sagar Lonial, MD^4* and Anita K. Gandhi, PhD⁵

¹Bristol Myers Squibb, Princeton, NJ
²Hematology Department, Institut Català d'Oncologia - Hospitalet, IDIBELL, University of Barcelona, Barcelona, Spain
³Department of Hematology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands, and Cancer Center Amsterdam, Amsterdam, Netherlands
⁴Winship Cancer Institute, Emory University, Atlanta, GA
⁵Hematology, Translational Medicine, Bristol Myers Squibb, Summit, NJ

Fernando Carreño, PhD^1*, Morrys C Kaisermann, MD, PhD^2*, Jacqueline L Egger, PhD^3* and Geraldine Ferron-Brady, PharmD, PhD^1*

¹Clinical Pharmacology Modeling and Simulation, GSK, Upper Providence, PA
²Clinical Development-Oncology, GSK, Upper Providence, PA
³Clinical Development, GSK, London, United Kingdom

Ajay K. Nooka, MD, MPH¹, Tara Cochrane, MBBS, FRCPA, FRACP^2,3, Anita D'Souza, MD, MS^4*, Jeffrey V Matous, MD⁵, Peter M. Voorhees, MD⁶, Karthik Ramasamy, MBBS, PhD^7*, Aurore Perrot, MD, PhD⁸, Andrew Spencer, MBBS^9*, Cyrille Hulin, MD^10*, Hang Quach, MD, FRACP, FRCPA, MBBS¹¹, Deeksha Vishwamitra¹², Ashley Nguyen^12*, Debopriya Ghosh, PhD^13*, Elizabeth Shearin, PharmD^14*, Gary E Mason, MD, MS^12*, Thomas Renaud, MD¹³ and Gurdeep Parmar, MBBS^15*

¹Emory University, Winship Cancer Institute, Atlanta, GA
²Department of Haematology, Gold Coast University Hospital, Southport, QLD, Australia
³Gold Coast University Hospital and Griffith University, Gold Coast, QLD, Australia
⁴Medical College of Wisconsin, Milwaukee, WI
⁵Sarah Cannon Research Institute, Colorado Blood Cancer Institute, Denver, CO
⁶Atrium Health Levine Cancer Institute, Charlotte, NC
⁷Oxford University Hospitals, NHS Foundation Trust, Oxford, United Kingdom
⁸Centre Hospitalier Universitaire de Toulouse, Oncopole, Toulouse, France
⁹Alfred Health-Monash University, Melbourne, VIC, Australia
¹⁰Hôpital Haut Leveque, University Hospital, Pessac, France
¹¹St. Vincent's Hospital Melbourne, East Melbourne, Australia
¹²Janssen Research & Development, Spring House, PA
¹³Janssen Research & Development, Raritan, NJ
¹⁴Janssen-Cilag Benelux, Spring House, PA
¹⁵Illawarra Shoalhaven Local Health District, Warrawong, Australia

Enrique M Ocio, MD, PhD^1*, Aurore Perrot, MD, PhD², Pierre Bories, MD^3*, Jesús F. San-Miguel, MD, PhD⁴, Lionel Karlin^5*, Joaquin Martinez-Lopez, MD, PhD^6*, Song-Yau Wang, MD^7*, Sara Bringhen, MD, PhD⁸, Maria-Victoria Mateos, MD, PhD⁹, Paula Rodríguez-Otero, MD, PhD^10*, Stefania Oliva, MD, PhD^11*, Axel Nogai, MD^12*, Bruno Paiva, PhD^4*, Yi Li, PhD^13*, Eric Le Bras, PhD^14*, Sandrine Macé, PhD^14*, Ercem Kodas, PhD^14*, Helgi Van de Velde, MD, PhD¹⁵ and Philippe Moreau, MD, PhD^16*

¹Hospital Universitario Marqués de Valdecilla (IDIVAL), Universidad de Cantabria, Santander, Spain
²CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France
³Early Phase Unit, University Cancer Institute Toulouse Oncopole, Toulouse, France
⁴Clinica Universidad de Navarra (CCUN), Center for Applied Medical Research (CIMA), IDISNA, CIBER-ONC, Pamplona, Spain
⁵Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France
⁶Department of Hematology, Hospital Universitario 12 de Octubre, CNIO, Universidad Complutense de Madrid, Madrid, Spain
⁷Department of Hematology and Oncology, University of Leipzig, Leipzig, Germany
⁸SSD Clinical Trials, Onco-Ematologia e Myeloma Multiplo, AOU Città della Salute e della Scienza di Torino, Torino, Italy
⁹University Hospital of Salamanca/IBSAL/Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain
¹⁰Department of Hematology, Centre for Applied Medical Research, Cancer Center Clinica Universidad de Navarra, University of Navarra, IdiSNA, CIBERONC, Pamplona, Spain
¹¹Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy
¹²Charité Medical University, Berlin, Germany
¹³Sanofi, Bejing, China
¹⁴Sanofi, R&D, Vitry-sur-Seine, France
¹⁵Sanofi R&D, North America, Cambridge, MA
¹⁶Department of Hematology, Nantes University Hospital, Nantes, France

Jiamin Fang^1*, Xiaoyan Liu^1* and Fuling Zhou, PhD²

¹Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China
²Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China

Huixing Zhou^1*, Long Chang^2*, Jie Ma^3*, Jingnan Sun^4*, Hua Xue^5*, Yanping Ma^6*, Hongming Huang^7*, Hebing Zhou^8*, Liping Su⁹, Zhenling Li^10*, Hai Zhou^11*, Wenrong Huang¹², Jun Luo, MD^13*, Jing Jia^14*, Hongmei Jing¹⁵, Guohong Su^16*, Jihao Zhou, MD, PhD^17*, Biyun Chen^18*, Guoxiang Zhang^19*, Wenming Chen^20*, Jian Li, MD²¹ and Wen Gao²²

¹Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China
²Peking Union Medical College Hospital, Beijing, China
³Department of Hematology, The First Affiliated Hospital of Zhengzhou University, zhengzhou, China
⁴The First Hospital of Jilin University, Changchun, CHN
⁵Affiliated Hospital of Hebei University, Baoding, China
⁶Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan, China
⁷The Affiliated Hospital of Nantong University, Jiangsu, IL, CHN
⁸Department of Hematology, Beijing Luhe Hospital, Capital Medical University, Beijing, China
⁹Shanxi Province Cancer Hospital, Taiyuan, China
¹⁰China-Japan Friendship Hospital, Beijing, China
¹¹Department of Hematology, Qilu Hospital of Shandong University, Jinan, China
¹²Lymphoma & Plasma Cell Disease Department of Hematology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
¹³Department of Haematology, THE FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY, Nanning, China
¹⁴Beijing Chao-Yang Hospital, Beijing, China
¹⁵Peking University Third Hospital, Beijing, CHN
¹⁶Cangzhou Central Hospital, Cangzhou, CHN
¹⁷Department of Hematology, Shenzhen People’s Hospital, Shenzhen, China
¹⁸Fujian Provincial Hospital， Fujian Medical University, Fuzhou, CHN
¹⁹Heping Hospital Affiliated to Changzhi Medical College, Changzhi, China
²⁰Department of Hematology, Beijing Chao-Yang Hospital of Capital Medical University, Beijing, China
²¹Department of Hematology, Peking Union Medical College Hospital, Beijing, China
²²Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China

Efstathios Kastritis, MD^1*, Monique C Minnema^2*, Meletios-Athanasios Dimopoulos¹, Giampaolo Merlini, MD, PhD^3*, Foteini Theodorakakou, MD^1*, Despina Fotiou, MD^1*, Antoine Huart, MD^4*, Karim Belhadj Merzoug^5*, Stavros Golfinopoulos, MD, MSc, MBA^6*, Nasia Antoniou, MSc, PhD^6*, Giorgos Psarros, MSc^6*, Pieter Sonneveld, MD⁷ and Giovanni O. Palladini, MD, PhD³

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
²Department of Hematology, University Medical Center Utrecht, Utrecht, Netherlands
³Amyloidosis Research and Treatment Center, University of Pavia, Pavia, Italy
⁴Department of Nephrology and Organs Transplantation, CHU de Toulouse Rangueil, Toulouse, France
⁵Lymphoid Malignancies Unit, Henri Mondor Hospital, Créteil, France
⁶Health Data Specialists, Dublin, Ireland
⁷Department of Hematology, Erasmus Medical Centre, University Hospital Rotterdam, Rotterdam, Netherlands

Daren Yabi^1*, Pierre-Edouard Debureaux, MD², Zoe van De Wyngaert, MD^3*, Pauline Caillard, MD^4*, Murielle Roussel, MD^5*, Marguerite Vignon, MD^6*, Thomas Chalopin, MD^7*, Nathalie Forgeard, MD^8*, Tristan Vaugeois, MD^8*, Alexis Talbot, MD^9*, Bertrand Arnulf, MD¹⁰, Camille Cohen, MD, PhD^11* and Stephanie Harel, MD^8*

¹Immuno-Hematology Unit, Saint-Louis Hospital, AP-HP, Paris, France
²Immuno-Hematology Unit, Saint Louis Hospital, APHP, Paris, France
³Department of Clinical Hematology and Cellular Therapy, Sorbonne University, Saint Antoine Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France
⁴Nephrology, CHU Limoges, Limoges, France
⁵Hématologie Clinique, CHU de Limoges, Limoges, France
⁶Hematology, Cochin Hospital, Greater Paris University Hospitals (AP-HP), Paris, France
⁷Hematology, Centre hospitalier universitaire de Tours, Tours, FRA
⁸Department of Immuno-hematology, Hôpital Saint Louis, APHP, Paris, France
⁹Immuno Hematology Unit, Saint Louis Hospital, Paris, France
¹⁰Immuno-hematology, Saint Louis Hospital, Paris Cedex 10, France
¹¹Nephrology, Bichat Hospital, AP-HP, Paris, FRA

Ricardo D. Parrondo, MD¹, Saurav Das, MD^2*, Hanna Sledge^3*, Abiola Bolarinwa, MBBS, FMCPath^4*, Jamie Elliott, ANP^5*, Andre Fernandez, P.A. -C^1*, David O. Hodge^3*, Leif Bergsagel, MD⁶, Rafael Fonseca, MD⁷, Prashant Kapoor, MD⁸, Francis Buadi, MD⁴, Morie A. Gertz, MD⁴, Angela Dispenzieri, MD⁴, Vivek Roy, MD¹, Taimur Sher, MD^9*, Moritz Binder, MD⁴, Nadine Abdallah, MD⁸, Saurabh Chhabra, MBBS^10*, S. Vincent Rajkumar, MD^4*, Wilson I. Gonsalves, MD¹¹, Joselle Cook, MBBS⁴, David Dingli, MD, PhD⁴, Saurabh Zanwar, MD^4*, Yi Lin, MD, PhD⁴, Eli Muchtar, MD⁴, Caitlin Wilson^5*, Udit Yadav, MBBS^10*, Rahma M Warsame, MD⁴, J E Wiedmeier-Nutor, MD, MPH¹⁰, Taxiarchis Kourelis, MD⁴, Nelson Leung, MD¹², Madhu Nagaraj, MD^4*, Mustaqeem A. Siddiqui, MD, MBA⁴, Linda B. Baughn, PhD¹³, Shaji Kumar, MD⁴, Asher A. Chanan-Khan, MD¹ and Sikander Ailawadhi, MD¹

¹Division of Hematology-Oncology, Mayo Clinic-Florida, Jacksonville, FL
²Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
³Department of Quantitative Health Sciences, Mayo Clinic Florida, Jacksonville, FL
⁴Division of Hematology, Mayo Clinic, Rochester, MN
⁵Mayo Clinic Florida, Jacksonville
⁶Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ
⁷Division of Hematology, Mayo Clinic, Paradise Valley, AZ
⁸Mayo Clinic, Rochester, MN
⁹Division of Hematology, Mayo Clinic, Jacksonville, FL
¹⁰Division of Hematology/Oncology, Mayo Clinic Arizona, Phoenix, AZ
¹¹Division of Hematology, Mayo School of Graduate Medical Education, Rochester, MN
¹²Division of Nephrology, Hematology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
¹³Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN

David H. Vesole, MD, PhD¹, Thomas G. Martin, MD², Suzanne Trudel, MD, MSc³, Henning Schade^4*, Samantha Shenoy, NP^5*, Noa Biran, MD¹, Jeffrey Lee Wolf, MD⁶, Jeffrey V Matous, MD⁷, Pamela Munster^8*, Savannah Berkeley^8* and Jesús G Berdeja, MD⁹

¹Division of Multiple Myeloma, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ
²University of California, San Francisco, San Francisco, CA
³Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, Canada
⁴Colorado Blood Cancer Institute, Colorado
⁵Hematology, University of California, San Francisco, San Francisco, CA
⁶Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA
⁷Colorado Blood Cancer Institute, Denver, CO
⁸UCSF, San Francisco, CA
⁹Tennessee Oncology, Nashville, TN

Nisha S. Joseph, MD¹, Jonathan L. Kaufman, MD¹, Craig C. Hofmeister, MD¹, Vikas A. Gupta, MD PhD¹, Bryan J Burton, BSc^1*, Roseann M Pruitt^1*, Ajay K. Nooka, MD, MPH², Madhav V. Dhodapkar, MD PhD¹ and Sagar Lonial, MD^1,2*

¹Winship Cancer Institute of Emory University, Atlanta, GA
²Winship Cancer Institute, Emory University, Atlanta, GA

Rakesh Popat¹, Charlotte Pawlyn, PhD^2,3, Robert Cicero, MSc^4*, Andrew Hall^5*, Ceri Bygrave, MBBCh MRCP FRCPath^6*, Dean Smith, BA(Hons) MBBS MRCP FRCPath MD(Res)^7*, Simona Degli Esposti^8*, Daniel Frank Larkin^9*, Gordon Cook, PhD, DSc^10*, Matthew W. Jenner^11*, Martin F Kaiser, MD^3,12, Lydia Sarah Hui Lee, MD PhD^13*, Amrutha Sridhar^1*, Marzia Rahman^1*, Hanna Renshaw, MD, BA^1*, Jennifer Ryan^14*, Victoria Ware^15*, Thea Chandler^16*, Laura Clayton^5*, Sadie Roberts^17*, Sarah R Brown, PhD^17* and Christopher Parrish, MBBChir, MRCP, FRCPath, MA, PhD¹⁰

¹NIHR UCLH Clinical Research Facility, University College London Hospitals NHS Foundation Trust, London, United Kingdom
²Institute of Cancer Research, Sutton, United Kingdom
³The Royal Marsden NHS Foundation Trust, London, United Kingdom
⁴Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom
⁵Cancer Research UK Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom
⁶Department of Haematology, Cardiff & Vale University Health Board, Cardiff, United Kingdom
⁷School of Medicine, University of Nottingham, Nottingham, United Kingdom
⁸NIHR Biomedical Research Centre At Moorfields Eye Hospital NHS Foundation Trust, London, GBR
⁹Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, GBR
¹⁰Leeds Teaching Hospitals NHS Trust, Leeds Cancer Centre, Leeds, United Kingdom
¹¹University Hospital Southampton, Southampton, United Kingdom
¹²The Institute of Cancer Research, London, ENG, United Kingdom
¹³Research Department of Haematology, University College London, London, United Kingdom
¹⁴Nottingham University Hospital, Nottingham, United Kingdom
¹⁵Cardiff and Wales University Health Board, Cardiff, United Kingdom
¹⁶Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
¹⁷Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom

Hira Mian, MD¹, Muhamed Baljevic, MD², Hila Magen^3*, Moshe E Gatt, MD⁴, Irit Avivi Mazza^5*, Emma Searle, MD, PhD^6*, Eben I Lichtman, MD⁷, John T. McKay^8*, Torben Plesner, MD^9*, Cesar Rodriguez, MD^10*, Neha Korde, MD¹¹, Hana Safah, MD¹², Iuliana Vaxman, MD, BA^13*, Chetasi Talati, MD^14*, Anders Erik Svensson, MD^15*, Ziyi Jin, MS^15*, Shane Lee, MS^15*, Thomas Doerr, MSc^15*, Rajvineeth Kumar Pothacamury, MD^15*, Tanya S Rosenberg, MD^15*, Akshanth R Polepally, PhD^16*, Jeremy A. Ross, PhD, MBA^14* and Shaji Kumar, MD¹⁷

¹McMaster University, Hamilton, ON, Canada
²Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
³Department of Hematology, Sheba MC, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⁴Department of Hematology, Hadassah Medical Center and Hebrew University of Jerusalem, Jerusalem, Israel
⁵Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
⁶The Christie NHS Foundation Trust, Manchester, United Kingdom
⁷UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC
⁸Wake Forest University School of Medicine, Winston-Salem, NC
⁹Vejle Hospital and University of Southern Denmark, Vejle, Denmark
¹⁰Division of Hematology-Oncology, Department of Internal Medicine, Mount Sinai, New York, NY
¹¹Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹²Tulane Cancer Center, New Orleans, LA
¹³Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, MN, Israel
¹⁴AbbVie, Inc., North Chicago, IL
¹⁵AbbVie Inc., North Chicago, IL
¹⁶AbbVie Inc., Danville, CA
¹⁷Division of Hematology, Mayo Clinic, Rochester, MN

Thomas Chalopin, MD^1*, Hélène Demarquette^2*, Andrea Pieragostini^3*, Cécile Sonntag, MD^4*, Caroline Jacquet, MD^5*, Zoe van De Wyngaert, MD^6*, Anne Rumpler^7*, Murielle Roussel, MD^8*, Gaelle Labouré^9*, Veronique Morel, MD^10*, Laure Vincent, MD^11*, Valéry Salle^12*, Elise Cellerin^13*, Titouan Cazaubiel^14* and Salomon Manier, MD, PhD¹⁵

¹Centre Hospitalier Universitaire de Tours, Tours, France
²CH Dunkerque, Dunkerque, France
³Hematology, CHU Dijon, Dijon, France
⁴Centre Hospitalier Universitaire Hautepierre, Strasbourg, FRA
⁵CHU de Nancy, Vandoeuvre Les Nancy, FRA
⁶Department of Clinical Hematology and Cellular Therapy, Sorbonne University, Saint Antoine Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France
⁷CHU de Besançon, Besançon, France
⁸Hématologie Clinqiue, CHU de Limoges, Limoges Cedex 1, FRA
⁹Centre Hospitalier Robert Boulin, Libourne, France
¹⁰Clinical Hematology, Pitie-Salpetriere Hospital, APHP, Sorbonne Universite, Paris Cedex 13, FRA
¹¹Department of Clinical Hematology, Hôpital St Eloi, CHU de Montpellier, Montpellier, France
¹²CHU d’Amiens, Amiens, FRA
¹³Centre Hospitalier Universitaire de Tours, Tours, AL, France
¹⁴CHU De Bordeaux, Bordeaux, FRA
¹⁵Centre Hospitalier Universitaire - Hôpital Huriez, Lille, France

Charlotte Pawlyn, PhD^1,2, Faith E Davies, MD³, Gordon Cook, PhD, DSc^4,5*, Heather McIntyre^4*, Jeanine Richards^4*, Sharon Jackson^4*, Elizabeth Hodson^4*, Catherine Olivier^4*, Anna Hockaday^4*, John R Jones^6,7,8*, Martin F Kaiser, MD^1,2, Matthew W. Jenner^9*, Walter Martin Gregory, PhD^4*, Ruth M de Tute, MSc, PhD, FRCPath^10*, Roger G Owen, MD, MRCP, FRCPath^10*, Mark Drayson^11*, David A. Cairns, PhD^12*, Gareth Morgan, M.D., Ph.D.^3* and Graham Jackson, MD^13*

¹The Institute of Cancer Research, London, United Kingdom
²The Royal Marsden NHS Foundation Trust, London, United Kingdom
³NYU Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, NY
⁴Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom
⁵Leeds Teaching Hospitals NHS Trust, Leeds Cancer Centre, Leeds, United Kingdom
⁶Kings College Hospital, London, United Kingdom
⁷Brighton and Sussex Medical School, Brighton, United Kingdom
⁸East Sussex NHS Trust, Eastbourne, United Kingdom
⁹University Hospital Southampton, Southampton, United Kingdom
¹⁰HMDS, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
¹¹University of Birmingham, Institute of Immunology and Immunotherapy, Birmingham, United Kingdom
¹²Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom
¹³University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom

Ida Bruun Bruun Kristensen^1*, Hanne Marie Norseth, MD^2,3*, Diana Loigom^4*, Henrik Gregersen, MD^5*, Einar Haukås, MD^6*, Tobias S. S. Slørdahl, MD, PhD^7,8, Robert Schou Pedersen, MD, PhD^9*, Damian L. Szatkowski, MD¹⁰, Fredrik Schjesvold, MD, PhD^3,11 and Thomas Lund, MD, PhD^1,12

¹Department of Hematology, Odense University Hospital, Odense, Denmark
²University of Oslo, Oslo, Norway
³Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway
⁴Centre of Haematology, North Estonia Medical Centre Foundation, Tallinn, AL, Estonia
⁵Department of Haematology, Aalborg University Hospital, Aalborg, Denmark
⁶Department of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway
⁷Department of Hematology, St. Olavs University Hospital, Trondheim, Norway
⁸Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
⁹Dept. of Hematology, Regionshospital Goedstrup, Goedstrup, Denmark
¹⁰Førde Central Hospital, Førde, NOR
¹¹KG Jebsen Center for B Cell Malignancies,, University of Oslo, Oslo, Norway
¹²Centre for Innovative Medical Technology, University of Southern Denmark, Odense, DNK

Yue Guo, PhD^1*, Jin Niu^1*, Natalia A Quijano Cardé^1*, Liviawati Wu^2*, Xin Miao^1*, Shalla Hanson^1*, Yaming Su^3*, Carlos Pérez Ruixo^4*, Deeksha Vishwamitra¹, Katherine Chastain, MD³, Mahesh Samtani^3*, Weirong Wang^1* and Nahor Haddish-Berhane^1*

¹Janssen Research & Development, Spring House, PA
²Janssen Research & Development, South San Francisco, CA
³Janssen Research & Development, Raritan, NJ
⁴Janssen-Cilag, Madrid, Spain

Lu-Gui Qiu¹, Gang An^2*, Baijun Fang^3*, Xiaobing Huang, MD, PhD^4*, Yan Xu, MD^5*, Yuzhang Liu^3*, Feifei Che^6*, Xinai Yang^7*, Xianlin Duan^7*, Peng Shao^7* and Xiaoyan Kang^7*

¹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
²State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology&Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, China
³Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China
⁴Sichuan Academy of Medical Sciences, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China
⁵State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Boston, MA
⁶Department of Hematology, Sichuan Academy of Medical Sciences, Sichuan Provincial People’s Hospital,, Chengdu, China
⁷Clinical Research and Development Center, Qilu Pharmaceutical Co., Ltd., Jinan 250100, China., Jinan, China

Evangelos Terpos, MD, PhD¹, Maria Gavriatopoulou^1*, Alexandros Spyridonidis, MD, PhD^2*, Emmanouil Spanoudakis, MD, PhD^3*, Anastasia Sioni, MD^4*, Eirini Katodrytou^5*, Eleftheria Hatzimichael, MD, PhD^6*, Maria Kotsopoulou, MD^7*, Nikolaos Giannakoulas, MD, PhD^8*, Ioannis Ntanasis-Stathopoulos, MD, PhD, MSc^1*, Panagiotis Malandrakis, MD^1*, Despina Fotiou, MD^1*, Magdalini Migkou, MD^1*, Foteini Theodorakakou, MD^1*, Vasiliki Spiliopoulou, MD^1*, Nasia Antoniou, MSc, PhD^9*, Nikolaos Kanellias^1*, Anastasia Pouli, MD, PhD⁴, Efstathios Kastritis, MD^1* and Meletios Dimopoulos, MD¹

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
²Hematology Division, Department of Internal Medicine, University of Patras, Medical School, Patras, Greece
³Department of Hematology, Democritus University of Thrace Medical School, Alexandroupolis, Greece
⁴Hematology Department, "St. Savvas" Oncology Hospital, Athens, Greece
⁵Department of Hematology, Theagenio Cancer Hospital, Athens, Greece
⁶Department of Hematology, Faculty of Medicine, University of Ioannina, Ioannina, Greece
⁷Department of Hematology, Metaxa Cancer Hospital, Piraeus, Greece
⁸Department of Hematology of University Hospital of Larisa, Faculty of Medicine, University of Thessaly, Larisa, Greece
⁹Health Data Specialists, Dublin, Ireland

Fredrik Schjesvold, MD, PhD¹, Tomas Jelinek, MD, PhD^2*, Kamila Polgarova, MD, PhD^3*, Ludek Pour, PhD^4*, Sung-Soo Yoon, M.D., Ph.D.⁵, Won Seog Kim, MD^6*, Alexander Fosså, MD, PhD^7*, Jesús F. San-Miguel, MD, PhD⁸, Miguel Canales, MD, PhD^9*, Paula Rodríguez-Otero, MD, PhD^10*, Albert Oriol, MD, PhD^11*, Javier de la Rubia^12*, Joaquín Martínez-Lopez^13*, Sonia González De Villambrosia^14*, Prashant Kapoor, MD¹⁵, Ola Landgren¹⁶, James Edward Hoffman, MD^17*, Noopur Raje¹⁸, Hongfang Wang, PhD^19*, Kunal Jhunjhunwala, PhD^20*, Liang Zhao, PhD^21*, Zhini Wang, MS^21*, Mony Morisse, PhD^20*, Helgi Van de Velde, MD, PhD¹⁹ and Nitya Nathwani, MD²²

¹Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway
²Department of Hematooncology, University Hospital Ostrava and Faculty of Medicine University of Ostrava, Ostrava, Czech Republic
³First Department of Medicine, First Faculty of Medicine, Charles University and General Hospital, Prague, Czech Republic
⁴Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine Masaryk University, Brno, Czech Republic
⁵Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
⁶Samsung Medical Center, Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
⁷Department of Oncology, Oslo University Hospital, Oslo, Norway
⁸Cancer Center Clinica Universidad de Navarra, CIMA, IDISNA, Pamplona, Spain
⁹Cancer Center Clinica Universidad de Navarra, Pamplona, Spain
¹⁰Clinica Universidad de Navarra, Madrid, Spain
¹¹Hematology, Catalan Institute of Oncology and Josep Carreras Institute, Hospital Germans Trias i Pujol, Badalona, Spain
¹²Hospital Universitario y Politécnico La Fe, Valencia, Spain
¹³Department of Hematology, Hospital Universitario 12 de Octubre, CNIO, Universidad Complutense de Madrid, Madrid, Spain
¹⁴Hematology Department, Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain
¹⁵Mayo Clinic, Rochester, MN
¹⁶Sylvester Comprehensive Cancer Center, Miami, FL
¹⁷Sylvester Comprehensive Cancer Center, Myeloma Service, University of Miami, Miami, FL
¹⁸Massachusetts General Hospital, Boston, MA
¹⁹Sanofi R&D, North America, Cambridge, MA
²⁰Sanofi, Cambridge, MA
²¹Sanofi, Shanghai, China
²²Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA

Karen Sweiss, PharmD¹, Kyeongmin Kim, PhD Candidiate^2*, Yizhen Guo, PhD^2*, Kasey Hill, PhD^2*, Nicole Abbott, PhD^2*, Matias Eugenio Sanchez, MD³, Chukwuemeka Uzoka, MD³, Ana Maria Avila Rodriguez, MD³, John G Quigley⁴, Nadim Mahmud, MBBS, PhD⁵, Damiano Rondelli, MD^6*, Douglas W Sborov, MD⁷, Donald Harvey, PharmD^8*, Ajay K. Nooka, MD, MPH⁹, Madhav V. Dhodapkar, MD PhD¹⁰, Jonathan L. Kaufman, MD¹⁰, Nisha S. Joseph, MD¹⁰, Sagar Lonial, MD^10*, Pritesh Patel, MD^3*, Mitch A. Phelps, PhD^2* and Craig C. Hofmeister, MD¹⁰

¹Department of Pharmacy Practice, University of Illinois at Chicago, Hinsdale, IL
²The Ohio State University, Columbus, OH
³Division of Hematology/Oncology, University of Illinois at Chicago, Chicago, IL
⁴Division of Hematology/Oncology, University of Illinois, Chicago, Chicago, IL
⁵Section of Hematology/Oncology, Department of Medicine, Univ. of Illinois at Chicago, Chicago, IL
⁶Division of Hematology/Oncology, University of Illinois College of Medicine, Chicago, IL
⁷Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
⁸Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
⁹Winship Cancer Institute of Emory University, Atlanta
¹⁰Winship Cancer Institute of Emory University, Atlanta, GA

Fan Wang^1*, Heiko Babel^2*, Vanessa Schmitt^2*, Muhammad Erfan Uddin, PhD^1*, Muhamed Baljevic, MD³, Peter M. Voorhees, MD⁴, Cesar Rodriguez, MD^5*, Shaji Kumar, MD⁶, Hira Mian, MD⁷, Anders Erik Svensson, MD^1*, Chetasi Talati, MD¹, Sven Mensing^2*, Rajeev M Menon, PhD^1*, Benjamin Engelhardt^2* and Akshanth R Polepally, PhD^8*

¹AbbVie Inc., North Chicago, IL
²AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany
³Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
⁴Plasma Cell Disorders Section, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Center, Charlotte, NC
⁵Division of Hematology-Oncology, Department of Internal Medicine, Mount Sinai, New York, NY
⁶Division of Hematology, Mayo Clinic, Rochester, MN
⁷McMaster University, Hamilton, ON, Canada
⁸AbbVie Inc., Danville, CA

Rachid Baz, MD¹, Mark B. Meads, PhD^2*, Jongphil Kim, PhD^3*, Ariel F. Grajales-Cruz, MD⁴, Brandon Blue⁴, Sonila Toska, MEd^1*, Xiaohong Zhao, MD, PhD^1*, Xiaofei Song, PhD^3*, Praneeth Reddy Sudalagunta, PhD^5*, Alexandra Achille^1*, David R. Noyes, MS^1*, Samer Sansil^6*, Sean J. Yoder, MS^7*, Ariosto Siqueira Silva, PhD^8*, Omar Castaneda, MD⁹, Jose L. Ochoa-Bayona, MD^10*, Chaomei H. Zhang^7*, Ciara Louise Freeman, PhD, MSc, FRCPC, MRCP⁹, Hien Liu, MD¹¹, Doris K. Hansen, MD^10*, Taiga Nishihori, MD¹², Melissa Alsina, MD¹⁰ and Kenneth H. Shain, MD, PhD²

¹Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
²H. Lee Moffitt Cancer Center, Tampa, FL
³Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁴H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁵Department of Metabolism and Physiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
⁶H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
⁷Molecular Genomics Core Facility, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
⁸Department of Metabolism and Physiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁹Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
¹⁰Moffitt Cancer Center, Tampa, FL
¹¹Department of Blood and Marrow Transplant and Cellular Immunotherapy, , H. Lee Moffitt Cancer Center, Tampa, FL
¹²Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL

Muhamed Baljevic, MD¹, Nizar J. Bahlis, MD², Rami Kotb, MD³, Gary J. Schiller, MD⁴, Brea Lipe, MD⁵, Sumit Madan, MD⁶, Heather J. Sutherland, MD, PhD, FRCPC⁷, Suzanne Lentzsch, MD, PhD⁸, Natalie Callander, MD⁹, Noa Biran, MD¹⁰, Dane Van Domelen^11*, Tomer Mark^11* and Darrell White, MD, MSc¹²

¹Vanderbilt University Medical Center, Nashville, TN
²University of Calgary, Charbonneau Cancer Research Institute, Calgary, AB, Canada
³Cancer Care Manitoba, Winnipeg, MB, Canada
⁴David Geffen School of Medicine, University of California, Los Angeles, CA
⁵University of Rochester, Rochester, NY
⁶Banner MD Anderson Cancer Center, Gilbert, AZ
⁷Vancouver General Hospital, Vancouver, BC, Canada
⁸Columbia University, New York, NY
⁹University of Wisconsin, Carbone Cancer Center, Madison, WI
¹⁰Hackensack University Medical Center, Hackensack, NJ
¹¹Karyopharm Therapeutics, Newton, MA
¹²Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, NS, Canada

Chengcheng Fu^1*, Jing Wang^2*, Song Jin^1*, Lingzhi Yan^1*, Jingjing Shang^1*, Weiqin Yao^1*, Xiaolan Shi^1*, Zhi Yan^1* and Depei Wu, MD, PhD³

¹The First Affiliated Hospital of Soochow University, Suzhou, China
²Soochow Hopes Hematonosis Hospital, Suzhou, China
³Department of Hematology, The first Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center of Hematologic Diseases, Suzhou, China

Peng Liu, MD^1,2, Junling Zhuang, MD, PhD³, Zhongjun Xia, MD^4*, Bingzong Li, MD, PhD⁵, Songfu Jiang, MD, PhD^6*, Yian Zhang, MD^1*, Wei Wang, MD, PhD^7*, Xiaoqin Chen, MD, PhD^8*, Xiaohui Zhang, MD^9* and Shujuan Zhou, MD, PhD^10*

¹Hematology, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China
²Cancer center, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China
³Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, China
⁴Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
⁵Department of Hematology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
⁶The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
⁷Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
⁸Department of Hematological Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, China
⁹The Second Affiliated Hospital of Soochow University, Suzhou, China
¹⁰Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China

Tereza Popkova, MD^1,2*, Jakub Radocha, MD, PhD³, Martin Stork^4*, Jiří Minařík⁵, Jan Straub^6*, Alexandra Jungova^7*, Petr Pavlicek^8*, Tomas Jelinek, MD, PhD^1,2*, Vladimir Maisnar, MD, PhD^3*, Ludek Pour, PhD^4*, Tomas Pika^5*, František Sedlák, MD^6*, Jan Soukup^8*, Hana Plonkova, MD^1,2*, Ludmila Muronova^1,2*, Viera Sandecka, MD^4*, Petra Krhovska, MD^5*, David Zihala^1,2* and Roman Hajek^1,2

¹Department of Haematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
²Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic
³4th Department of Internal Medicine-Hematology, University Hospital Hradec Kralove, Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic
⁴Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
⁵Department of Hemato-Oncology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic
⁶1st Medical Department – Clinical Department of Haematology, First Faculty of Medicine and General Teaching Hospital Charles University, Prague, Czech Republic
⁷Hematology and Oncology Department, Charles University Hospital Pilsen, Pilsen, Czech Republic
⁸Department of Internal Medicine and Hematology, University Hospital Kralovske Vinohrady, Prague, Czech Republic

Pieter Sonneveld, MD¹, Meletios A. Dimopoulos², Mario Boccadoro, MD³, Hang Quach, MD, FRACP, FRCPA, MBBS⁴, Phoebe Joy Ho, MBBS⁵, Meral Beksac^6*, Cyrille Hulin, MD^7*, Elisabetta Antonioli^8*, Xavier Leleu⁹, Silvia Mangiacavalli, MD^10*, Aurore Perrot, MD, PhD¹¹, Michele Cavo, MD^12*, Angelo Belotti, MD^13*, Annemiek Broijl, PhD¹⁴, Francesca Gay, MD, PhD^15*, Roberto Mina^15*, Inger S. Nijhof^16,17*, Niels W.C.J. van de Donk, MD, PhD^16*, Eirini Katodritou^18*, Fredrik Schjesvold, MD, PhD¹⁹, Anna Sureda Balari, MD, PhD²⁰, Laura Rosiñol Dachs^21*, Michel Delforge^22*, Wilfried Roeloffzen^23*, Christoph Driessen²⁴, Annette Vangsted^25*, Hermann Einsele, MD²⁶, Andrew Spencer, MBBS^27*, Roman Hajek, MD, PhD²⁸, Artur Jurczyszyn^29*, Sarah Lonergan^14*, Yanfang Liu^30*, Jianping Wang^31*, Emilie M.J. van Brummelen^32*, Veronique Vanquickelberghe^33*, Anna Sitthi-Amorn^31*, Carla J. de Boer^32*, Robin Carson, MD³¹, Eva G. Katz^34*, Katharine S. Gries^34*, Jiaqi Song^30*, Kai Fai Ho^35*, Paula Rodríguez-Otero, MD, PhD^36*, Joan Bladé, MD, PhD^37* and Philippe Moreau, MD, PhD^38*

¹Erasmus MC Cancer Institute, Rotterdam, Zuid-Holland, Netherlands
²National and Kapodistrian University of Athens, Athens, Greece
³University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy
⁴University of Melbourne, St. Vincent’s Hospital, Melbourne, VIC, Australia
⁵Royal Prince Alfred Hospital and University of Sydney, Camperdown, NSW, Australia
⁶Ankara Liv Hospital, Istinye University, Ankara, Turkey
⁷Hôpital Haut Lévêque, University Hospital, Pessac, France
⁸Careggi Hospital and University of Florence, Firenze, Italy
⁹University of Poitiers, CHU and Inserm 1313, Poitiers, France
¹⁰IRCCS Fondazione Policlinico San Matteo, Pavia, Italy
¹¹CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France
¹²IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy
¹³Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
¹⁴Erasmus MC Cancer Institute, Rotterdam, Netherlands
¹⁵AOU Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy
¹⁶Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
¹⁷St Antonius Hospital, Nieuwegein, Netherlands
¹⁸Theagenion Cancer Hospital, Thessaloniki, Greece
¹⁹Oslo Myeloma Center, and KG Jebsen Center for B-cell Malignancies, University of Oslo, Oslo, Norway
²⁰Hematology Department, Institut Català d'Oncologia - Hospitalet, IDIBELL, University of Barcelona, Barcelona, Spain
²¹Hospital Clinic de Barcelona, IDIBAPS, Barcelona, Spain
²²University of Leuven, Leuven, Belgium
²³Department of Hematology, University Medical Center Groningen, Groningen, Netherlands
²⁴Cantonal Hospital St. Gallen, St. Gallen, Switzerland
²⁵Rigshospitalet, Copenhagen, Denmark
²⁶Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
²⁷Alfred Health-Monash University, Melbourne, VIC, Australia
²⁸University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
²⁹Jagiellonian University Medical College, Kraków, Poland
³⁰Janssen Global Services, LLC, Shanghai, China
³¹Janssen Research & Development, LLC, Spring House, PA
³²Janssen Research & Development, LLC, Leiden, Netherlands
³³Janssen Research & Development, Beerse, Belgium
³⁴Janssen Global Services, LLC, Raritan, NJ
³⁵STAT-TU, Inc, Toronto, ON, Canada
³⁶Cancer Center Clínica Universidad de Navarra, Pamplona, Spain
³⁷Hematology, Hospital Clínic de Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona; and GEM/PETHEMA, Barcelona, Spain
³⁸University Hospital Hôtel-Dieu, Nantes, France